112 related articles for article (PubMed ID: 11273129)
1. Worsening of steroid depending bronchial asthma following rifampicin administration.
Dhanoa J; Natu M; Massey S
J Assoc Physicians India; 1998 Feb; 46(2):242. PubMed ID: 11273129
[No Abstract] [Full Text] [Related]
2. Worsening of steroid dependent asthma : A possible role of rifampicin.
Gupta D; Yadav S; Behera D; Jindal SK
Indian J Chest Dis Allied Sci; 1995; 37(1):35-8. PubMed ID: 16892737
[TBL] [Abstract][Full Text] [Related]
3. Adverse effect of rifampicin administration on steroid-dependent asthma.
Powell-Jackson PR; Gray BJ; Heaton RW; Costello JF; Williams R; English J
Am Rev Respir Dis; 1983 Aug; 128(2):307-10. PubMed ID: 6349444
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of reduced bioavailability of rifampicin.
Joshi SR
J Assoc Physicians India; 1999 Sep; 47(9):943-4. PubMed ID: 10778683
[No Abstract] [Full Text] [Related]
5. [A case of miliary tuberculosis with interstitial nephritis due to re-administration of rifampicin treated successfully with steroid].
Kawasaki T; Sasaki Y; Dan A; Bekku R; Hashimoto T; Tamaki M; Yamagishi F
Kekkaku; 2008 Jul; 83(7):519-24. PubMed ID: 18709970
[TBL] [Abstract][Full Text] [Related]
6. Editorial: Rifampicin.
Med J Aust; 1973 Nov; 2(19):876. PubMed ID: 4765871
[No Abstract] [Full Text] [Related]
7. Rifampicin/pyrazinamide therapy should not be used for latent tuberculosis infection.
Garca-Doval I
J Am Acad Dermatol; 2004 May; 50(5):801; author reply 801-2. PubMed ID: 15097974
[No Abstract] [Full Text] [Related]
8. Gynaecomastia during antituberculosis chemotherapy with isoniazid.
Dixit R; Sharma S; Nawal CL
J Assoc Physicians India; 2008 May; 56():390-1. PubMed ID: 18700651
[No Abstract] [Full Text] [Related]
9. Rifampicin induced non-responsiveness to steroids in bronchial asthma.
Jain NK; Madan A; Jhamaria JP; Sharma TN; Mathur DK; Singh DP
Indian J Chest Dis Allied Sci; 1989; 31(4):271-4. PubMed ID: 2638668
[No Abstract] [Full Text] [Related]
10. Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection.
Stout JE
Expert Opin Drug Saf; 2004 May; 3(3):187-98. PubMed ID: 15155147
[TBL] [Abstract][Full Text] [Related]
11. [Examination of administrative dosage of cyclosporine during anti-tuberculosis chemotherapy including rifampicin].
Matsui Y; Akagawa S; Kawashima M; Suzuki J; Masuda K; Tamura A; Nagai H; Nagayama N; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2007 Jul; 82(7):563-7. PubMed ID: 17695786
[TBL] [Abstract][Full Text] [Related]
12. Comparison of a short course of prednisolone with sustained-release theophylline in the control of nocturnal asthma.
Chhabra SK
Indian J Chest Dis Allied Sci; 1995; 37(1):7-14. PubMed ID: 16892732
[TBL] [Abstract][Full Text] [Related]
13. Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis.
Ena J; Valls V
Clin Infect Dis; 2005 Mar; 40(5):670-6. PubMed ID: 15714411
[TBL] [Abstract][Full Text] [Related]
14. Bronchospasm induced by inhalant corticosteroids: the role of ethanol.
Antonicelli L; Micucci C; Bonifazi F
Allergy; 2006 Jan; 61(1):146-7. PubMed ID: 16364174
[No Abstract] [Full Text] [Related]
15. [Acute tubulointerstitial nephritis following treatment with rifampicin].
Riska H; Tornroth T
Bull Int Union Tuberc; 1984 Sep; 59(3):148-9. PubMed ID: 6518324
[No Abstract] [Full Text] [Related]
16. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
Ribera E; Azuaje C; Lopez RM; Domingo P; Curran A; Feijoo M; Pou L; Sánchez P; Sambeat MA; Colomer J; Lopez-Colomes JL; Crespo M; Falcó V; Ocaña I; Pahissa A
J Antimicrob Chemother; 2007 Apr; 59(4):690-7. PubMed ID: 17307771
[TBL] [Abstract][Full Text] [Related]
17. [The simultaneous use of rifampicin and other antitubercular agents with oral contraceptives].
Reimers D; Jezek A
Prax Pneumol; 1971 May; 25(5):255-62. PubMed ID: 5556355
[No Abstract] [Full Text] [Related]
18. Adverse drug reactions observed during DOTS.
Dhingra VK; Rajpal S; Aggarwal N; Aggarwaln JK; Shadab K; Jain SK
J Commun Dis; 2004 Dec; 36(4):251-9. PubMed ID: 16506547
[TBL] [Abstract][Full Text] [Related]
19. Status of drug resistance in tuberculosis after the introduction of rifampicin in India.
Paramasivan CN
J Indian Med Assoc; 2003 Mar; 101(3):154-6. PubMed ID: 14603961
[TBL] [Abstract][Full Text] [Related]
20. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
Santha T; Rehman F; Mitchison DA; Sarma GR; Reetha AM; Prabhaker R;
Trop Med Int Health; 2004 May; 9(5):551-8. PubMed ID: 15117298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
